Stem cell trial for early Alzheimer’s disease begins at UTHealth Houston
A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway at UTHealth Houston. In Alzheimer’s disease, deposits of beta-amyloid and tau lead to the buildup of plaques and tangles in the brain, which…
First infusion in Houston for new Alzheimer’s drug administered at UTHealth Houston
UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer’s disease. The recipient was 79-year-old Terrie Frankel. “We’re making history today,” Frankel said. Frankel began experiencing memory loss…
Pages